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With the beginning of 2011 Springer has launched, after
consultation with Ignasi Carrió, Editor-in-Chief of the
European Journal of Nuclear Medicine and Molecular
Imaging (EJNMMI), a companion journal, EJNMMI Re-
search. With the increasing number of manuscripts that
cannot be published by the EJNMMI because of reasons
other than insufficient quality – space, redundancy, target
audience etc. – it became obvious that there was a need for
another forum where high-quality nuclear medicine re-
search features could be communicated [1]. It was also
clear that Open Access (OA) was the key to a rapid and
wide dissemination of scientific results. A great number of
funding organisations all over the world already require or
at least encourage grant recipients to make their results
available according to the OA paradigm. The costs of
publication are lower than in traditional journals; and they
are supported by the authors or their institutions rather than
by the readers via subscription. The number of institutions
across Europe and elsewhere that are members or support-
ing members of OA publishers, and consequently support
the publication costs, is constantly growing.
EJNMMI Research will publish basic, translational and
clinical research in nuclear medicine and related fields. It is
conceived as a platform for rapid communication and lively
debate. Therefore, besides original manuscripts and in-
depth reviews, interesting preliminary results should be
submitted. In the same spirit, short communications and
selected reports on unusual or rare conditions of general
interest will be published. Editorials and letters to the editor
should foster scientific exchange. Finally, educational
material that deepens and enlarges understanding and
knowledge in fields of high scientific interest is also
welcome.
All submissions will be peer reviewed using criteria of
scientific quality equivalent to those for the EJNMMI and
comparable international journals. After acceptance, manu-
scripts will be rapidly available through the journal website
(www.springer.com/13550) at Springer or at BioMed Central
(www.ejnmmires.com). Manuscripts will immediately be
indexed by PubMed Central as well as other web services
such as Google, etc. This fast and broad availability is the
great advantage of OA journals. Who has never been
frustrated by refusal of access to a potentially interesting
publication because his/her institution has no subscription to
a given journal or publisher? Usually one would not cite a
publication without studying the full text, as this is the only
way to appreciate the quality and reliability of the results.
OA gives immediate access to the full text of any publication
to anybody who has an Internet connection; it is obvious
that this overall availability of the complete data will favour
citation.
BioMed Central currently publishes over 200 peer-
reviewed journals. More than half of them are indexed
by Thomson Reuters (ISI), and many have already
achieved remarkable impact factors. It is our ambition
to guide EJNMMI Research into the club of renowned
international journals. However, we need the contribution
of all scientists working in the field of nuclear medicine
and related sciences. We rely both on authors who are
confident in this new approach to publication and
dissemination of scientific results and knowledge and on
reviewers who ensure that the appropriate quality stand-
ards are met.
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The new journal should not be understood as a
competitor for the EJNMMI. The two journals share the
same goal, to publish interesting and outstanding research
data in the field of targeted imaging and therapy in basic,
translational and clinical sciences. The means used to
achieve this goal are different. There will inevitably be
some overlap but we hope to keep it as small as possible.
We are currently putting in place a mechanism that
invites authors of papers that cannot be considered for
publication in the EJNMMI to submit their work to
EJNMMI Research. This should not be understood to
imply that EJNMMI Research is a second-choice journal.
Among the 81% of original papers rejected by the
EJNMMI, many merit publication but cannot be accom-
modated by the EJNMMI mainly because of lack of space.
I am grateful to Ignasi Carrió for his contributions in
creating and shaping this new journal, in particular for
agreeing to further accompany EJNMMI Research in the
position of Associate Editor. As for myself, I will continue
to function as Associate Editor of the EJNMMI. I am
confident that this dual affiliation will allow us to closely
follow the evolution of both journals and make the right
decisions at the right time. For obvious reasons, a great
number of the members of the Editorial Board of the
EJNMMI Research are also on the EJNMMI Editorial
Board. I take this opportunity to thank all the members of
the new Editorial Board for having accepted this addi-
tional task, knowing that all of them already have more
than enough activities on their plate. I especially thank
them for their comments, spanning the entire spectrum
from benevolent to enthusiastic.
Finally, EJNMMI Research will not be linked to the
European Association of Nuclear Medicine and consequently
will not publish guidelines or society news. We will,
however, be happy to consider the publication of papers
resulting from studies performed under the guidance of
EANM Committees or the EARL (EANM Research Ltd).
We are very much looking forward to joining you all in
the introduction and distribution of this new form of
scientific communication in the field of nuclear medicine.
I apologise in advance for any inconsistencies, delays or
other problems that might arise at the beginning. We all
know that any achievement depends on eagerness to learn,
constancy of effort, and critical evaluation but also on
humility – and a little bit of luck – from the learning phase
onward. We will take care of the first four items in this list
and trust in the fifth!
We look forward to receiving your manuscripts at www.
springer.com/13550 or www.ejnmmires.com
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